Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)
When carrying out an ELISA assay it is important to prepare your samples in order to achieve the best possible results
Ren P, Wang J, Li N, Li G, Ma H, Zhao Y, et al
The Definitive Safety and Sourcing Protocol The efficacy and safety of any advanced biohacking protocol hinge entirely on two factors: medical supervision and product purity
Additionally, Core Med Science products are GMO-free, gluten-free, and soy-free
It requires a hospital stay